Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5

Brian Imbiakha1, Shahrzad Ezzatpour2, David W Buchholz1

  • 1Department of Microbiology and Immunology, Cornell University, College of Veterinary Medicine, Ithaca, NY, 14853, USA.

Science Advances
|September 22, 2023
PubMed

Insights

The Omicron BA.5 variant of SARS-CoV-2 causes severe disease and mortality in mice, unlike BA.1. This study identifies a new mouse model for studying Omicron BA.5 pathogenesis and developing countermeasures.

Area of Science:

  • Virology
  • Immunology
  • Pathology

Background:

  • Pathology studies of SARS-CoV-2 variants of concern (VOC) are limited by the absence of suitable animal models.
  • Previous Omicron variants (BA.1, BA.2) showed minimal pathogenicity in K18-hACE2 transgenic mice.

Purpose of the Study:

  • To establish a rodent model for SARS-CoV-2 Omicron BA.5 pathogenesis.
  • To investigate the pathogenicity differences between Omicron BA.1 and BA.5.

Main Methods:

  • Infection of K18-hACE2 transgenic mice with SARS-CoV-2 Omicron BA.1 and BA.5.
  • Assessment of morbidity, mortality, viral loads, and lung pathology.
  • Analysis of inflammatory markers in bronchoalveolar lavage fluid.

Main Results:

  • Omicron BA.5 caused significant morbidity, mortality (100% in 5-8 month old mice), weight loss, and lung pathology, unlike Omicron BA.1.
  • Higher early viral loads correlated with increased BA.5 pathogenicity.
  • Neither BA.1 nor BA.5 replicated in the brain, differing from prior SARS-CoV-2 variants.

Conclusions:

  • SARS-CoV-2 Omicron BA.5 establishes a pathogenic phenotype in K18-hACE2 mice, providing a valuable model for pathogenesis and antiviral studies.
  • Comparative analysis of BA.1 and BA.5 pathogenicity elucidates viral determinants of disease severity.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
314
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
339
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K